[Pericardial devascularization with splenectomy for the treatment of portal hypertension]

[Pericardial devascularization with splenectomy for the treatment of portal hypertension] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Pericardial devascularization with splenectomy for the treatment of portal hypertension] Abstract Text:

Z Yang,F Qiu,

OBJECTIVE: To review our experiences in and evaluate the efficacy of pericardial devascularization with splenectomy for the treatment of portal hypertension. METHODS: From May 1972 to October 1999, 508 patients with portal hypertension were treated with this operation. 319 of them had posthepatitic cirrhosis, and 141 late stage schistosomiasis or accompanied chronic viral hepatitis. RESULTS: The bleeding control rate was 94.1%, and the overall operative mortality rate was 4.5%. The major causes of death were upper gastrointestinal bleeding, intraabdominal hemorrhage, hepatic failure and hepatorenal syndrome. The mean follow-up time was 3.8 years. The 5-year survival rate was 94.1%, and the 10-year survival 70.7%. The 5-year recurrent bleeding rate was 6.2%. The 10-year recurrent bleeding rate was 13.3%. The rate of postoperative hepatic encephalopathy was 2.5% at 5 years, and 4.1% at 10 years. CONCLUSIONS: Pericardial devascularization with splenectomy was the first choice for the treatment of portal hypertension, especially for posthepatitic cirrhosis. The following were our experience: (1) thorough porto-azygos disconnection; (2) performing the operation in according to pericardial anatomy with correct surgical techniques; (3) selection of operative candidates and opportunity; (4) emphasizing perioperative management and preventing complications.

[Pericardial devascularization with splenectomy for the treatment of portal hypertension] Publishing Authors By Initials

Z Yang,F Qiu,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

[Pericardial devascularization with splenectomy for the treatment of portal hypertension] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery

VOLUME: 38

Page Numbers: 645-8

Journal Abbreviation: Zhonghua Wai Ke Za Zhi

ISSN: 0529-5815

DAY: 8

MONTH: Sep

YEAR: 2000

[Pericardial devascularization with splenectomy for the treatment of portal hypertension] Information

Number of References:

LANGUAGE: chi

NlmUniqueID: 153611

[Pericardial devascularization with splenectomy for the treatment of portal hypertension] Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: [Pericardial devascularization with splenectomy for the treatment of portal hypertension] Information

Substance Name:

Registry Number:

Grant and Affiliation Information for [Pericardial devascularization with splenectomy for the treatment of portal hypertension]

AFFILIATION: Department of Surgery, Tongji Hospital, Tongji Medical University, Wuhan, China.

Country: China

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Zhonghua Wai Ke Za Zhi

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Pericardial devascularization with splenectomy for the treatment of portal hypertension Related Publications

• Frequency of loss expression of the DPC4 protein in various locations of biliary tract carcinoma.
• [A1166C polymorphism of the angiotensin II type 1 receptor gene and essential hypertension in Han, Tibetan and Yi populations]
• [Application of electro-acupuncture-anesthesia device in brachiplex nerve blocking]
• [Application of recombinant human activated protein C with blood product administration and deep vein thrombosis in severe sepsis]
• [Cause and mortality analysis of acute intracranial hypertension and cerebral edema in pediatric intensive care unit]
• [Clinical analysis on 21 cases of enterobiasis in nasal cavity]
• [Cloning and expression of two garlic virus coat protein genes]
• [Comparison of the effectiveness of chemotherapy and autologous hematopoietic stem cell transplantation as postremission treatment for adult acute lymphoblastic leukemia patients]
• [Determination of As, Hg and Mo in niuhuang jiedu tablets and other Chinese traditional medicines with graphite furnace AAS]
• [Determination of lead in tinplate by ICP-AES]
• [Enrichment and determination of trace chlorobenzene compounds in water]
• [In vivo degradation and tissue compatibility of polyphosphazene blend films]
• [Mechanical ventilation support for acute respiratory distress syndrome induced by severe sepsis and septic shock.]
• [Meta-analysis on curative effects of surgical procedures for intrahepatic bile duct lithiasis]
• [Pericardial devascularization with splenectomy for the treatment of portal hypertension]
• [Rapid determination of allethrin, permethrin and piperonyl butoxide in insecticidal aerosol for household by gas chromatography]
• [Role of the B lymphocytes in children with infectious mononucleosis caused by Epstein-Barr Virus]
• [Simultaneous determination of phenol and aniline in waste water by absorbance ratio derivative method]
• [Spectral diagnosis of dielectric barrier plasma discharge at atmospheric pressure and its application to surface modification of materials]
• [Studies on difference of fluorescence activity and elution order of propranolol enantiomers by reversed-phase high performance liquid chromatography]
• [Study on occupational respiratory diseases in fur-processing workers]
• [The determination of olaquindox in feeds by HPLC]
• [The expression of CD133 in acute leukemia and its clinical significance]
• [The identification of cortex from Kalopanax septemlobus and its confusions]
• [The inhibition pathway of the EBV-immortalized cells in children with infectious mononucleosis]
• [Therapeutic strategy of pediatric severe sepsis.]
• [Timing of surgical treatment for gallstone pancreatitis]
• [Trace analysis of Zn-doped compound semiconductor material by resonant ionization mass spectrometry]
• [Treatment with sedation and blood sugar control on severe sepsis.]
• [Trend of the CD23+ B cells in children with infectious mononucleosis caused by Epstein-Barr virus]